https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Catalyst_Pharmaceuticals%2C_Inc.Catalyst Pharmaceuticals, Inc. - Revizia istoricului2026-04-06T15:30:52ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Catalyst_Pharmaceuticals,_Inc.&diff=414197&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Catalyst Pharmaceuticals, Inc. listata cu simbolul US.CPRX ==Descriere companie== Catalyst Pharmaceuticals, Inc. (www.catalystpharma.com) is a commercial-stage, patient-centric biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing medicines for patients living with rare diseases. The Company is developing a pipeline of medicines for other rare diseases. The Company's product Firdapse Tablet, 10 mg, is use...2024-09-18T17:46:59Z<p>Pagină nouă: Pagina dedicata companiei Catalyst Pharmaceuticals, Inc. listata cu simbolul US.CPRX ==Descriere companie== Catalyst Pharmaceuticals, Inc. (www.catalystpharma.com) is a commercial-stage, patient-centric biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing medicines for patients living with rare diseases. The Company is developing a pipeline of medicines for other rare diseases. The Company's product Firdapse Tablet, 10 mg, is use...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Catalyst Pharmaceuticals, Inc. listata cu simbolul US.CPRX<br />
<br />
==Descriere companie==<br />
Catalyst Pharmaceuticals, Inc. (www.catalystpharma.com) is a commercial-stage, patient-centric biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing medicines for patients living with rare diseases. The Company is developing a pipeline of medicines for other rare diseases. The Company's product Firdapse Tablet, 10 mg, is used for the treatment of adults with Lambert-Eaton Myasthenic Syndrome (LEMS) patients (ages 17 and above) in the United States and Canada. Firdapse consists of the phosphate salt of amifampridine. It is developing a long-acting formulation of amifampridine phosphate. The Company's Firdapse is also developing clinical trials for the treatment of muscle-specific receptor tyrosine kinase-positive myasthenia gravis (MuSK-MG). Catalyst Pharmaceuticals Ireland, Ltd. is the subsidiary of the Company.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.CPRX" /><br />
<br />
==Ultimele stiri despre Catalyst Pharmaceuticals, Inc. (US.CPRX)==<br />
<dynamicpagelist><br />
category=US.CPRX<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.CPRX]][[Categorie:Stiri despre companii]]</div>Admin